| Name | MAO-B-IN-16 |
|---|
| Description | MAO-B-IN-16 is a selective monoamine oxidase B (MAO-B) inhibitor, with an IC50 of 1.55 µM. MAO-B-IN-16 can be used in the study of central nervous disorders, such as parkinson's disease[1]. |
|---|---|
| Related Catalog | |
| Target |
hMAO-B:1.55 μM (IC50) hMAO-A:>100 μM (IC50) |
| In Vitro | MAO-B-IN-16 (compound 4h) (10 μM; 24 h) has no cytotoxic effect on human neuroblastoma cells[1]. Cell Viability Assay[1] Cell Line: SH-SY5Y cells Concentration: 10 μM Incubation Time: 24 h Result: Showed no cytotoxic effect on cells with cellular viability of 99%. |
| References |
| Molecular Formula | C18H19NO3 |
|---|---|
| Molecular Weight | 297.35 |